Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial

Autor: Apolo, Andrea B., Powles, Thomas, Escudier, Bernard, Burotto, Mauricio, Zhang, Joshua, Simsek, Burcin, Scheffold, Christian, Motzer, Robert J., Choueiri, Toni K.
Zdroj: In European Journal of Cancer December 2022 177:63-71
Databáze: ScienceDirect
Externí odkaz: